|
|
|
|
 |
SAN DIEGO--- Optimer Pharmaceuticals Announces Change to Board of Directors |
| Companies mentioned in this article: |
|
Optimer Pharmaceuticals |
|
| 7/17/2008 @ 9:21 PM
print this article -
email to a friend -
join our eNewsletter
|
 |
Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) today announced that Martin C. Muenchbach, Ph.D., an Investment Manager at Bellevue Asset Management AG, has notified the Company that he will be stepping down from his position as a member of the Board of Directors as of August 1, 2008. Dr. Muenchbach joined the Board in December 2005, advising Optimer as a private company and then working with the Company in its transition to a public company. Dr. Muenchbach’s departure is not related to relations with the board members or with the company. Dr. Muenchbach will continue to follow his pursuits in venture capital, serving on the Board of many privately held companies. Optimer is currently in the process of identifying candidates to serve on its Board of Directors.
“We would like to thank Martin for his many contributions and dedicated service to the Company. His board experience and leadership have been invaluable as the company has grown from a private company through its maturation as a public company," said Michael N. Chang, Ph.D., CEO and President of Optimer. “We wish him great success in his future endeavors.”
About Optimer Pharmaceuticals
Optimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing innovative anti-infective products for the treatment of serious infections. Optimer has two late-stage anti-infective product candidates. OPT-80, currently in two pivotal Phase 3 clinical trials, is being developed for the treatment of Clostridium difficile infection, the most common hospital-acquired diarrhea. Prulifloxacin, also in two pivotal Phase 3 clinical trials, is an antibiotic being developed for the treatment of travelers’ diarrhea, a form of infectious diarrhea. Additional information regarding Optimer can be found at www.optimerpharma.com. |
| Tech People On the Move - California |
|
|
| |
| Friday, September 5, 2008 |
 |
|
CARLSBAD--- Invitrogen Names Joe Beery Senior Vice President, Chief Information Officer Posted 7:26 AM PST
|
| |
| Thursday, September 4, 2008 |
|
|
SAN JOSE--- Intel’s Ken Tallo Elected Chair of the Open SystemC Initiative Posted 3:22 PM PST
OAKLAND--- Scientific Learning Chief Financial Officer to Depart Company Posted 3:12 PM PST
SAN JOSE--- Mark Carges Joins eBay To Lead Global Platform Development Posted 7:40 AM PST
WALNUT CREEK--- WildPackets Taps Industry Veteran Jim Laird as Vice President of Sales Posted 7:39 AM PST
SAN DIEGO--- DriveCam Announces Brandon Nixon as New CEO Posted 7:37 AM PST
|
| |
| Wednesday, September 3, 2008 |
|
|
EL DORADO HILLS--- Board Member Bob Lamvik to Join SAI Executive Staff as Chief Operating Officer Posted 3:16 PM PST
SAN DIEGO--- Qualcomm Appoints Robert Walton Senior Vice President and Division President of Qualcomm Enterprise Services Posted 3:09 PM PST
REDWOOD CITY--- Genelabs Technologies, Inc. Announces Appointment of Frederick W. Driscoll as President and CEO Posted 3:00 PM PST
LOS ANGELES--- Aqua Connect Inc. Appoints Paul Fiore to its Board of Directors Posted 6:30 AM PST
CARLSBAD--- Regulus Therapeutics Appoints Dr. Stelios Papadopoulos to Board of Directors Posted 6:29 AM PST
|
| |
| Tuesday, September 2, 2008 |
|
|
LOS GATOS--- Netflix Appoints Bill Holmes as V.P. of Business Development Posted 5:01 PM PST
SAN JOSE--- SunPower Promotes Howard Wenger to President, Global Business Units Posted 9:10 AM PST
SAN DIEGO--- Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives Posted 8:40 AM PST
SAN MATEO--- Composite Software Appoints VP of Alliances Posted 8:39 AM PST
PALO ALTO--- MyProductAdvisor.com Appoints New President Posted 8:34 AM PST
SAN FRANCISCO--- BitTorrent Appoints New Vps to its Management Team Posted 8:30 AM PST
SAN DIEGO--- Zhu Shen of BioForesight Joins Editorial Advisory Board of PharmAsia News Posted 8:10 AM PST
|
| |
| Friday, August 29, 2008 |
|
|
EL SEGUNDO--- Internet Brands Appoints Scott Friedman CFO Posted 2:38 PM PST
REDWOOD CITY--- Gary Read, President and CEO of Nimsoft, Appointed to Board of Directors of Scalable Software Posted 8:44 AM PST
SAN DIEGO--- Cadence Pharmaceuticals Appoints Todd Rich, M.D. to its Board of Directors and Names Malcolm Lloyd-Smith as Senior Vice President, Regulatory Affairs and Quality Assurance Posted 8:35 AM PST
SANTA CLARA--- GSI Technology, Inc. Announces New Director Posted 8:24 AM PST
|
| |
| Thursday, August 28, 2008 |
|
|
MILPITAS--- KLA-Tencor Appoints Mark P. Dentinger New Chief Financial Officer Posted 2:56 PM PST
MILPITAS--- President and COO John Kispert to Leave KLA-Tencor Posted 2:55 PM PST
|
| |
| Tuesday, August 26, 2008 |
|
|
LOS ANGELES--- Anodyne Medical Device, Inc. Announces Abbey Daniels as New Chief Executive Officer Posted 3:37 PM PST
SAN DIEGO--- Prometheus Announces New Chief Financial Officer Posted 8:49 AM PST
SAN MATEO--- Quantivo Appoints High-Tech Veterans to Executive Team Posted 8:36 AM PST
|
|
|
|
|
|
FreshNews.com Jobs Change DAILY
We Have 5,000 + Job Listings! Open Your FREE Account
Employers or Job Searchers Get Started Now! Click Here
|
